ID

17173

Descrizione

Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials; ODM derived from: https://clinicaltrials.gov/show/NCT00105352

collegamento

https://clinicaltrials.gov/show/NCT00105352

Keywords

versioni (1)
  1. 30/08/16 30/08/16 -
Caricato su

30 agosto 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes Mellitus, Type 1 NCT00105352

Inglese

Eligibility Diabetes Mellitus, Type 1 NCT00105352

1 moduli  
Criteria
Descrizione

Criteria

age 8 - 35 years at the time of inclusion
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
body weight > 30 kg
Descrizione

Body Weight

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005910
type 1 diabetes defined by: ada (american diabetes association) criteria or judgment of physician
Descrizione

Diabetes Mellitus, Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
duration of diabetes: 1 month to 3* years (*the trialnet coordinating center will monitor fasting c-peptide levels as they are reported to ensure that a wide range of values is included. this review may result in widening the duration of diabetes window to allow for subjects with low c-peptide).
Descrizione

Diabetes disease length | fasting C-peptide level | Low C-peptide levels

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011847
UMLS CUI [1,2]
C0872146
UMLS CUI [2]
C2208720
UMLS CUI [3]
C4013229
must maintain good glycemic control
Descrizione

Glycemic Index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1136206
be willing to travel to a trialnet clinical center for a minimum of four separate visits that are spaced 3-10 days apart, and be willing to complete the study within a six week period.
Descrizione

Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
actual treatment with drugs influencing beta cell function (e.g. oral hypoglycaemic agents, beta-2-receptor agonists)
Descrizione

Pharmaceutical Preparations Affecting beta Cell function | Oral hypoglycemic | Adrenergic beta-2 Receptor Agonists

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0030281
UMLS CUI [1,4]
C0031843
UMLS CUI [2]
C0359086
UMLS CUI [3]
C2936789
actual treatment with drugs influencing insulin sensitivity (e.g. steroids)
Descrizione

Pharmaceutical Preparations Affecting Insulin Sensitivity | Steroids

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0920563
UMLS CUI [2]
C0038317
significant concomitant disease likely to interfere with glucose metabolism (e.g. febrile illness within the prior 3 days)
Descrizione

Comorbidity Significant Interferes with glucose metabolism | Disorder characterized by fever

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0750502
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C0596620
UMLS CUI [2]
C0743841
expected poor compliance
Descrizione

Poor compliance Expected

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0032646
UMLS CUI [1,2]
C1517001
if a female of child-bearing age, currently pregnant or not using a form of birth control
Descrizione

Childbearing Potential Age Contraceptive methods | Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0001779
UMLS CUI [1,3]
C0700589
UMLS CUI [2]
C0032961
any other condition that by the judgement of the investigator may be potentially harmful to the patients
Descrizione

Condition At risk Patients

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0030705
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetes Mellitus, Type 1 NCT00105352

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Age
Item
age 8 - 35 years at the time of inclusion
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
body weight > 30 kg
boolean
C0005910 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes defined by: ada (american diabetes association) criteria or judgment of physician
boolean
C0011854 (UMLS CUI [1])
Diabetes disease length | fasting C-peptide level | Low C-peptide levels
Item
duration of diabetes: 1 month to 3* years (*the trialnet coordinating center will monitor fasting c-peptide levels as they are reported to ensure that a wide range of values is included. this review may result in widening the duration of diabetes window to allow for subjects with low c-peptide).
boolean
C0011847 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C2208720 (UMLS CUI [2])
C4013229 (UMLS CUI [3])
Glycemic Index
Item
must maintain good glycemic control
boolean
C1136206 (UMLS CUI [1])
Protocol Compliance
Item
be willing to travel to a trialnet clinical center for a minimum of four separate visits that are spaced 3-10 days apart, and be willing to complete the study within a six week period.
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Affecting beta Cell function | Oral hypoglycemic | Adrenergic beta-2 Receptor Agonists
Item
actual treatment with drugs influencing beta cell function (e.g. oral hypoglycaemic agents, beta-2-receptor agonists)
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0030281 (UMLS CUI [1,3])
C0031843 (UMLS CUI [1,4])
C0359086 (UMLS CUI [2])
C2936789 (UMLS CUI [3])
Pharmaceutical Preparations Affecting Insulin Sensitivity | Steroids
Item
actual treatment with drugs influencing insulin sensitivity (e.g. steroids)
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0920563 (UMLS CUI [1,3])
C0038317 (UMLS CUI [2])
Comorbidity Significant Interferes with glucose metabolism | Disorder characterized by fever
Item
significant concomitant disease likely to interfere with glucose metabolism (e.g. febrile illness within the prior 3 days)
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0596620 (UMLS CUI [1,4])
C0743841 (UMLS CUI [2])
Poor compliance Expected
Item
expected poor compliance
boolean
C0032646 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
Childbearing Potential Age Contraceptive methods | Pregnancy
Item
if a female of child-bearing age, currently pregnant or not using a form of birth control
boolean
C3831118 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
C0032961 (UMLS CUI [2])
Condition At risk Patients
Item
any other condition that by the judgement of the investigator may be potentially harmful to the patients
boolean
C0348080 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial